A Phase 2 Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies
This is a Phase 2 study to assess the efficacy of SB1518 in the treatment of patients with
advanced lymphoid malignancies including Hodgkin Lymphoma, Mantle Cell Lymphoma and Indolent
Lymphoma (follicular lymphoma, lymphoplasmacytic lymphoma, marginal zone lymphoma and small
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society